Zynex Inc (NASDAQ:ZYXI) CEO Thomas Sandgaard recently sat down with Proactive to discuss the medical device company's innovative solutions and impressive growth trajectory.   Sandgaard highlighted ho
ZYXI recently received the Food and Drug Administration clearance for its new TensWave device. TensWave is designed to provide a comprehensive pain management solution.
ENGLEWOOD, Colo. , Sept. 4, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
Zynex Inc (NASDAQ:ZYXI) announced that its portable pain management device TensWave has achieved Food and Drug Administration (FDA) clearance. The prescription-only TensWave device aims to provide pai
ENGLEWOOD, Colo. , Sept. 3, 2024 /PRNewswire/ -- Zynex Inc. (NASDAQ: ZYXI), a leading medical technology company specializing in non-invasive medical devices for pain management and rehabilitation, t
Growth versus value: It's a classic dilemma for investors. Choosing growth often demands a leap of faith—buying into a management team's vision of a significant commercial opportunity that may requi

Why Zynex Plunged Today

04:37pm, Friday, 26'th Jul 2024
Zynex missed on second-quarter revenue and earnings, and guided down. However, some of the near-term weakness was by design, as the company is cutting costs.

Why Is Zynex (ZYXI) Stock Down 24% Today?

08:46am, Friday, 26'th Jul 2024
Zynex (NASDAQ: ZYXI ) stock is falling on Friday following the release of the medical device maker's earnings report for the second quarter of 2024. This starts with diluted earnings per share of 4 c
U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Friday.
Zynex, Inc. (NASDAQ:ZYXI ) Q2 2024 Earnings Conference Call July 23, 2024 4:15 AM ET Company Participants Thomas Sandgaard - Chairman, President & Chief Executive Officer Dan Moorhead - Chief Financia
Zynex Inc. (ZYXI) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.09 per share a year ago.
Q2 2024 Revenue Increased 11% to $49.9 Million ENGLEWOOD, Colo. , July 25, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and

Zynex Sets Second Quarter 2024 Earnings Call

09:15am, Wednesday, 17'th Jul 2024
ENGLEWOOD, Colo. , July 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
ENGLEWOOD, Colo. , July 11, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
In 2021, a trader with a large Reddit following induced a massive rally in shares of GameStop Corp. NYSE: GME. The downtrodden gaming retailer was the most shorted stock in the entire market in Januar
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE